Abstract
The moral economy of American medicine has been transformed by contentious innovations in organization, administration, regulation, and finance. In many settings old fee-for-service incentives and disincentives have been replaced by those of ``managed care,'' while in other settings they have been diluted or distorted. In the everyday care of patients, old and new may alternate or interact. These innovations may also be having secondary effects on participation in life-sciences research and the development and employment of new technologies, discouraging collective support for preliminary investigation and delaying adoption of improved goods and services until cost-reducing potential has already been realized. This motivational complexity, particularly in its moral dimensions, is hard to address using standard assumptions and methods. I argue for different assumptions, based on the clinical behavior of individual patients rather than the market behavior of aggregated consumers, and I describe a different method, based on an old idea in political economy. I then present a new way to explain the core obligations of clinicians, researchers, and planners and to interpret the policy problems they must now share.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Robert Hunt Sprinkle, Profession of Conscience: The Making and Meaning of Life-Sciences Liberalism. Princeton: Princeton University Press, 1994.
James C. Scott, The Moral Economy of the Peasant: Rebellion and Subsistence in Southeast Asia. New Haven: Yale University Press, 1976.
William A. Munro, The Moral Economy of the State: Conservation, Community Development, and State Making in Zimbabwe. Athens: Ohio University Press, 1998.
Ira Studin, Strategic Healthcare Management: Applying the Lessons of Today's Top Management Experts to the Business of Managed Care. Burr Ridge, Illinois: Irwin, 1995, pp. 20–21.
Victor R. Fuchs, “Health economics,” The New Palgrave: A Dictionary of Economics, John Eatwell, Murray Milgate, and Peter Newman, eds. London: Macmillan, 1987, Vol II, pp. 614–619 at p. 616.
M. S. Feldstein, “The rising price of physicians services,” Review of Economics and Statistics, May 1970, vol. 52, pp. 121–133.
Harvey Leibenstein, “Bandwagon, snob, and Veblen effects in the theory of consumers demand,” Quarterly Journal of Economics May 1950; 64: 183–207. Laurie Simon Bagwell and B. Douglas Bernheim, Veblen effects in a theory of conspicuous consumption, American Economic Review June 1996; 86: 349–373.
Thorstein Veblen, The Theory of the Leisure Class [1899]. New York: Viking Penguin, 1967, pp. 68–101.
Robert Hunt Sprinkle, “Remodeling Health Care,” Journal of Health Politics, Policy and Law Spring 1994; 19:1, pp. 45–68.
Thomas Rice, The Economics of Health Reconsidered. Chicago: Health Administration Press, 1998.
William Stanley Jevons, “Chapter V: Theory of Labour,” in The Theory of Political Economy, 3rd ed., London: Macmillan, 1888, pp. 167–209.
Sprinkle, “Remodeling Health Care.”
A. Sommer, J. M. Tielsch and H. A. Quigley, et alii, “Racial Differences in the Cause-Specific Prevalence of Blindness in East Baltimore,” New England Journal of Medicine November 14, 1991; 325(20): 1412–1417.
Robert McCarthy, “As theWorld Churns: Medicare and HMOs,” Drug Benefit Trends 1998; 10(3): 19.
David S. Hilzenrath, “Medicine's Growing Battle: Getting Health Plans to Pay,” Washington Post, March 11, 1998, p. A1. David S. Hilzenrath, “MD Hospitals Say Plans Illegally Denied Claims,” Washington Post, April 22, 1998, p. C11.
Blaine Harden, “Maternity Wars: Hospitals Lure Medicaid Moms With Luxury, Convenience,” Washington Post, February 17, 1998, p. A1.
Gina Kolata and Kurt Eichenwald, “Health Business Thrives on Unproven Treatment, Leaving Science Behind,” New York Times, October 2, 1999, p. A1.
Sprinkle, Profession of Conscience.
Daniel Sherman, Amy Bradshaw, Myra Tanamor, and Chris Topoleski, Factors Affecting the Growth of Prescription Drug Expenditure. Washington, D.C.: The National Institute for Health Care Management Research and Educational Foundation, July 9, 1999.
Kenneth E. Clow, “Advertising health care services,” Journal of Health Care Marketing June 1, 1995; 15: 9. M.H. Waymack, “The ethics of selectively marketing the health maintenance organization,” Theoretical Medicine December 1990; 11: 4, pp. 301–309. David Segal, “HMOs want you: And they're taking surprisingly different approaches in the seasonal battle for the local market,” Washington Post, “Washington Business supplement,” November 13, 1995, pp. 12–14. S.M. Retchin, D.G. Clement and L.F. Rossiter, et alii, “How the elderly fare in HMOs: Outcomes from the Medicare competition demonstrations,” Health Services Research December 1992; 27: 5, pp. 651–669.
Judy Mann, “When coverage is denied, a legal cure,” Washington Post, February 12, 1997, p. C23.
Milton Friedman, “[A Friedman Doctrine –] The Social Responsibility of Business Is To Increase Its Profits,” New York Times Magazine, September 13, 1970, pp. 32ff.
Robert Hunt Sprinkle, “Corporatism in Question: A Note on Managed Care,” Report of the Institute for Philosophy and Public Policy Summer 1997; 17:3, pp. 13–17.
William B. Schwartz, M.D., Life Without Disease: The Pursuit of Medical Utopia. Berkeley: University of California Press, 1998.
Robert Hunt Sprinkle, “Essay-review of Schwartz,” Life Without Disease, in The Journal of Policy Analysis and Management, 18:4, pp. 705–713.
Robert Pear, “Medicare Billings FaceMore Delays,” New York Times, April 27, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sprinkle, R.H. A Moral Economy of American Medicine in the Managed-Care Era. Theor Med Bioeth 22, 247–268 (2001). https://doi.org/10.1023/A:1011446715065
Issue Date:
DOI: https://doi.org/10.1023/A:1011446715065